The Medicines and Healthcare products Regulatory Agency (MHRA) and the National Institute for Health and Care Excellence (NICE) have launched a call for evidence on resources developed under the Wellcome-funded Digital Mental Health Technologies (DMHT) programme. The survey opened on 5 November 2026 and will remain open until 26 February 2027.
The consultation forms part of the programme’s Phase 1 evaluation. According to the two organisations, it aims to establish how the resources have been received and used across the sector, and whether they have influenced users’ knowledge, confidence, decision-making and professional practice.
Who is being asked to respond
MHRA and NICE are seeking feedback from developers and manufacturers of digital mental health technologies, healthcare professionals, researchers, policymakers, regulators, people with lived experience of mental health conditions, carers and members of the public. Stakeholders are encouraged to take part whether they have used the resources extensively, minimally or not at all.
The resources are intended to support the safe development, regulation, evaluation and adoption of digital mental health technologies, including mental health apps and other digital tools. The survey will examine whether Phase 1 outputs met their intended objectives and will help inform the future direction of Phase 2.
According to the agencies, the feedback will help identify strengths, highlight areas for improvement and shape future work intended to improve the safety and effectiveness of digital mental health technologies. The findings are therefore expected to inform both the assessment of existing materials and planning for the programme’s next phase.